Arpitha Parthasarathy

Title: Arpitha Parthasarathy: Innovator in Cancer Treatment Technology

Introduction

Arpitha Parthasarathy is a notable inventor based in Takoma Park, MD (US). She has made significant contributions to the field of cancer treatment through her innovative work. Her research focuses on utilizing cold atmospheric plasma to selectively ablate cancer cells, showcasing her commitment to advancing medical technology.

Latest Patents

Arpitha holds a patent for a groundbreaking method titled "System and method for selective ablation of cancer cells with cold atmospheric plasma." This method involves elevating TRAIL-R1 expression in cancer cells to induce apoptosis. The process includes receiving electrical energy from an electrosurgical generator, converting the voltage and frequency, and applying cold plasma to cancer cells for a specified duration. The inert gas used in this method may include helium or argon, with a preferred application time of about 2 minutes.

Career Highlights

Arpitha is currently associated with U.S. Patent Innovations, LLC, where she continues to develop her innovative ideas. Her work is pivotal in the ongoing fight against cancer, and her patent reflects her dedication to improving treatment options for patients.

Collaborations

Arpitha collaborates with esteemed colleagues, including Alexey Shashurin and Michael Keidar. Their combined expertise enhances the research and development of advanced medical technologies.

Conclusion

Arpitha Parthasarathy is a pioneering inventor whose work in cancer treatment through cold atmospheric plasma is making a significant impact. Her innovative approach and dedication to research exemplify the potential of technology in improving healthcare outcomes.